Glucotrack, Inc. - 8-K Filing

Glucotrack acquired Lokahi Therapeutics for $53.5M total assets as part of a reverse stock split and merger, resulting in significant losses.

SEC EDGAR ·

Tickers: $GCTK

Read the full article at SEC EDGAR

More Regulatory news